ED Exposes Alleged Surrogacy Network
The Enforcement Directorate (ED) has revealed a vast illegal surrogacy and baby selling operation linked to Dr. Pachipala Namratha, uncovering a significant money trail involving approximately ₹40 crore in cash deposits and ₹20 crore in withdrawals. The operation spanned over a decade, covering regions like Hyderabad, Visakhapatnam, and Vijayawada.
Recently updated findings by the ED indicate that around 50 properties, cumulatively valued at ₹29.7 crore, have been provisionally attached as part of the investigation. These properties include hospital buildings and residential plots associated with Namratha.
Context and Importance of the Investigation
This investigation comes amid increasing concerns regarding illicit practices surrounding surrogacy in India. The ED’s actions aim to address these grave violations, highlighting the risks faced by vulnerable women manipulated into those situations for financial gain. The implications of such networks extend beyond individual cases, revealing systemic issues related to reproductive rights and healthcare regulation.
Unraveling the Financial Network
The ED’s provisional attachment order indicates a decade-long financial operation characterized by substantial cash inflows and outflows. Financial records show that between 2014 and July 2025, ₹40 crore was deposited into various bank accounts connected to Dr. Namratha and her associates, with ₹20 crore being withdrawn during the same period.
Investigation officials believe that these transactions were strategically designed to facilitate the cash payments to agents and acquire newborns from biological parents in distressing situations. The agency has detailed a three-tiered movement of funds, showcasing a complex structure aimed at obscuring the illegal activities.
Breakdown of Cash Flow
The first tier involved childless couples allegedly paying substantial amounts ranging from ₹20 lakh to ₹30 lakh for a child. These payments were made through various means such as bank transfers or cash directly into Namratha’s accounts.
In the second tier, funds were distributed to lead agents, including figures such as Dhanasri Santoshi. Large sums were immediately withdrawn in cash to further obscure their origins. Several significant cash transactions were found, including ₹14.60 lakh paid to an associate, SSS Sai Kumar.
The third tier detailed how payments reached biological parents, offering around ₹3.5 lakh for female infants and ₹4.5 lakh for male infants. Additionally, couriers and sub-agents were compensated with commissions of about ₹50,000 per case, which varied by delivery.
Discrepancies in Namratha’s Claims
Despite claims from Dr. Namratha that her financial gains stemmed from legitimate sources such as consultancy services and rental income, the ED has contested these explanations. Officials expressed skepticism regarding the volume of cash transactions occurring during periods when her medical license was reportedly suspended.
“The sheer amount of cash transactions raises serious suspicions about the sources of these funds. Our investigation is focused on clarifying this complex financial web,” said an ED spokesperson.
Properties Under Investigation
Among the assets provisionally attached by the ED are properties identified as Universal Srushti Hospital in Secunderabad, and a hospital building located in Vijayawada, along with another under-construction facility in Visakhapatnam.
Investigators have also flagged multiple residential properties, including flat units in Jayanth Towers, residential plots in Shilpa Enclave, and a villa in Palm Ridge Villas, Kondapur, where Namratha is known to reside. These properties illustrate the extensive reach of her alleged operations.
Additionally, more than 15 parcels of agricultural land in villages such as Balemarru and Dharanikota have also been included in the attached assets, signifying a broad investment strategy linked to the proceeds from these illegal activities.
Tracing the Trafficking Pattern
The ED’s analysis paints a disturbing picture of how financial transactions were designed to cover up the illegal purchase of children. The agency’s investigation suggests that the structured transaction pattern sought to pass off these illicit activities as legitimate medical and surrogacy expenses.
This systematic layering of transaction routes raises critical questions about regulatory oversight and enforcement of laws governing surrogacy and reproductive technologies in India. The focus on surrogacy as a viable option for childless couples must, therefore, be complemented by strict regulatory frameworks to prevent such abuses.
Future Directions in the Investigation
Looking ahead, the ED plans to deepen its inquiries into the connections between Namratha and various hospitals and agents associated with her operations. Ongoing investigations are expected to probe further into the network’s scale and the implications for child welfare laws.
“We are committed to ensuring accountability and will take all necessary steps to dismantle these networks,” stated the ED in a recent communication.
Public and Expert Reactions
The revelations surrounding Dr. Namratha’s operations have prompted significant public backlash and discussions among experts in reproductive rights. Advocacy groups have underscored the need for stronger legal protections for women and families involved in surrogacy arrangements.
Advocates argue that such scandals expose critical vulnerabilities in a system meant to support individuals seeking to create families. “My concern is for the women who are coerced into these circumstances. They become victims themselves in a system that is designed to be supportive,” a representative from a leading women’s rights organization asserted.
Legal Framework and Potential Reforms
In light of this case, legal experts have called for an urgent review of existing surrogacy laws. Many argue that enhancing regulations could help prevent future violations and better protect vulnerable populations.
“This situation serves as a wake-up call for policymakers to reassess the regulatory landscape surrounding surrogacy. It is imperative that safeguards are strengthened to avoid exploitation,” stated an authoritative voice in reproductive health law.
Conclusion and Next Steps
The investigation by the ED into Dr. Namratha’s alleged surrogacy racket remains a developing story as authorities work diligently to piece together the intricate web of financial transactions and illegal activities. Further updates are expected as their inquiries progress.
As India continues to grapple with the complexities of surrogacy legislation, the outcomes of this case may significantly influence how laws evolve going forward. With existing children’s and women’s rights at stake, the focus on ensuring justice remains paramount.
Authorities are anticipated to announce additional findings and potentially related arrests as they continue this critical investigation. The implications of this case will likely resonate within both the legal and medical communities as awareness grows about the need for more stringent regulations in surrogacy practices.